SCMG301 Assignment 2

Learning from Boston Scientific’s Risk Management Leadership Student Name Institution Course Professor Name Date Learning from Boston Scientific’s Risk Management Leadership Chapter 14 of Schlegel’s and Trent’s (2014) book highlights Boston Scientific as one of the companies that do not view uncertainty in the supply chain as an incidental aspect of its operations. The company expanded into a giant production firm of medical devices with over 24,000 workforce and thousands of items sold in over 100 countries. Schlegel and Trent (2014) argue that since the beginning of its operations, Boston Scientific identified supplier failures, regulatory delays, and market disruptions as significant threats to its performance, which is why it created one of the most well-designed supplier risk programs in the market compared to other companies. The firm developed a proactive system that is keen on risk driver identification, exposure determination, and disruption mitigati...